Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World Health Organization and the US National Heart Lung and Blood Institute to improve asthma awareness, prevention and management worldwide. GINA develops and publishes evidence-based, annually updated resources for cl...

Full description

Bibliographic Details
Main Authors: Mark L. Levy, Leonard B. Bacharier, Eric Bateman, Louis-Philippe Boulet, Chris Brightling, Roland Buhl, Guy Brusselle, Alvaro A. Cruz, Jeffrey M. Drazen, Liesbeth Duijts, Louise Fleming, Hiromasa Inoue, Fanny W. S. Ko, Jerry A. Krishnan, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu Yorgancıoğlu, Helen K. Reddel
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:npj Primary Care Respiratory Medicine
Online Access:https://doi.org/10.1038/s41533-023-00330-1
_version_ 1811166088873902080
author Mark L. Levy
Leonard B. Bacharier
Eric Bateman
Louis-Philippe Boulet
Chris Brightling
Roland Buhl
Guy Brusselle
Alvaro A. Cruz
Jeffrey M. Drazen
Liesbeth Duijts
Louise Fleming
Hiromasa Inoue
Fanny W. S. Ko
Jerry A. Krishnan
Kevin Mortimer
Paulo M. Pitrez
Aziz Sheikh
Arzu Yorgancıoğlu
Helen K. Reddel
author_facet Mark L. Levy
Leonard B. Bacharier
Eric Bateman
Louis-Philippe Boulet
Chris Brightling
Roland Buhl
Guy Brusselle
Alvaro A. Cruz
Jeffrey M. Drazen
Liesbeth Duijts
Louise Fleming
Hiromasa Inoue
Fanny W. S. Ko
Jerry A. Krishnan
Kevin Mortimer
Paulo M. Pitrez
Aziz Sheikh
Arzu Yorgancıoğlu
Helen K. Reddel
author_sort Mark L. Levy
collection DOAJ
description Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World Health Organization and the US National Heart Lung and Blood Institute to improve asthma awareness, prevention and management worldwide. GINA develops and publishes evidence-based, annually updated resources for clinicians. GINA guidance is adopted by national asthma guidelines in many countries, adapted to fit local healthcare systems, practices, and resource availability. GINA is independent of industry, funded by the sale and licensing of its materials. This review summarizes key practical guidance for primary care from the 2022 GINA strategy report. It provides guidance on confirming the diagnosis of asthma using spirometry or peak expiratory flow. GINA recommends that all adults, adolescents and most children with asthma should receive inhaled corticosteroid (ICS)-containing therapy to reduce the risk of severe exacerbations, either taken regularly, or (for adults and adolescents with “mild” asthma) as combination ICS–formoterol taken as needed for symptom relief. For patients with moderate–severe asthma, the preferred regimen is maintenance-and-reliever therapy (MART) with ICS–formoterol. Asthma treatment is not “one size fits all”; GINA recommends individualized assessment, adjustment, and review of treatment. As many patients with difficult-to-treat or severe asthma are not referred early for specialist review, we provide updated guidance for primary care on diagnosis, further investigation, optimization and treatment of severe asthma across secondary and tertiary care. While the GINA strategy has global relevance, we recognize that there are special considerations for its adoption in low- and middle-income countries, particularly the current poor access to inhaled medications.
first_indexed 2024-04-10T15:46:52Z
format Article
id doaj.art-dd505e9d9081431bb9d495ee006b72e6
institution Directory Open Access Journal
issn 2055-1010
language English
last_indexed 2024-04-10T15:46:52Z
publishDate 2023-02-01
publisher Nature Portfolio
record_format Article
series npj Primary Care Respiratory Medicine
spelling doaj.art-dd505e9d9081431bb9d495ee006b72e62023-02-12T12:04:55ZengNature Portfolionpj Primary Care Respiratory Medicine2055-10102023-02-0133111310.1038/s41533-023-00330-1Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) updateMark L. Levy0Leonard B. Bacharier1Eric Bateman2Louis-Philippe Boulet3Chris Brightling4Roland Buhl5Guy Brusselle6Alvaro A. Cruz7Jeffrey M. Drazen8Liesbeth Duijts9Louise Fleming10Hiromasa Inoue11Fanny W. S. Ko12Jerry A. Krishnan13Kevin Mortimer14Paulo M. Pitrez15Aziz Sheikh16Arzu Yorgancıoğlu17Helen K. Reddel18Locum General PractitionerDepartment of Pediatrics, Vanderbilt University Medical CenterDepartment of Medicine, University of Cape TownQuébec Heart and Lung Institute, Université LavalInstitute for Lung Health, Leicester NIHR BRC, University of LeicesterPulmonary Department, Mainz University HospitalDepartment of Respiratory Medicine, Ghent University HospitalProAR Foundation and Federal University of BahiaBrigham and Women’s Hospital and Department of Medicine, Harvard Medical SchoolDivisions of Respiratory Medicine and Allergology and Neonatology, Department of Pediatrics, Erasmus MC, University Medical Center RotterdamNational Heart and Lung Institute, Imperial CollegeDepartment of Pulmonary Medicine, Kagoshima University Graduate School of Medical and Dental SciencesDepartment of Medicine and Therapeutics, The Chinese University of Hong KongBreathe Chicago Center, University of Illinois ChicagoLiverpool University Hospitals NHS Foundation TrustHospital Santa Casa de Porto AlegreDepartment of Primary Care Research & Development, Usher Institute, University of EdinburghDepartment of Pulmonology, Celal Bayar UniversityThe Woolcock Institute of Medical Research and The University of SydneyAbstract The Global Initiative for Asthma (GINA) was established in 1993 by the World Health Organization and the US National Heart Lung and Blood Institute to improve asthma awareness, prevention and management worldwide. GINA develops and publishes evidence-based, annually updated resources for clinicians. GINA guidance is adopted by national asthma guidelines in many countries, adapted to fit local healthcare systems, practices, and resource availability. GINA is independent of industry, funded by the sale and licensing of its materials. This review summarizes key practical guidance for primary care from the 2022 GINA strategy report. It provides guidance on confirming the diagnosis of asthma using spirometry or peak expiratory flow. GINA recommends that all adults, adolescents and most children with asthma should receive inhaled corticosteroid (ICS)-containing therapy to reduce the risk of severe exacerbations, either taken regularly, or (for adults and adolescents with “mild” asthma) as combination ICS–formoterol taken as needed for symptom relief. For patients with moderate–severe asthma, the preferred regimen is maintenance-and-reliever therapy (MART) with ICS–formoterol. Asthma treatment is not “one size fits all”; GINA recommends individualized assessment, adjustment, and review of treatment. As many patients with difficult-to-treat or severe asthma are not referred early for specialist review, we provide updated guidance for primary care on diagnosis, further investigation, optimization and treatment of severe asthma across secondary and tertiary care. While the GINA strategy has global relevance, we recognize that there are special considerations for its adoption in low- and middle-income countries, particularly the current poor access to inhaled medications.https://doi.org/10.1038/s41533-023-00330-1
spellingShingle Mark L. Levy
Leonard B. Bacharier
Eric Bateman
Louis-Philippe Boulet
Chris Brightling
Roland Buhl
Guy Brusselle
Alvaro A. Cruz
Jeffrey M. Drazen
Liesbeth Duijts
Louise Fleming
Hiromasa Inoue
Fanny W. S. Ko
Jerry A. Krishnan
Kevin Mortimer
Paulo M. Pitrez
Aziz Sheikh
Arzu Yorgancıoğlu
Helen K. Reddel
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
npj Primary Care Respiratory Medicine
title Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
title_full Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
title_fullStr Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
title_full_unstemmed Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
title_short Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
title_sort key recommendations for primary care from the 2022 global initiative for asthma gina update
url https://doi.org/10.1038/s41533-023-00330-1
work_keys_str_mv AT markllevy keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT leonardbbacharier keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT ericbateman keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT louisphilippeboulet keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT chrisbrightling keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT rolandbuhl keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT guybrusselle keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT alvaroacruz keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT jeffreymdrazen keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT liesbethduijts keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT louisefleming keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT hiromasainoue keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT fannywsko keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT jerryakrishnan keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT kevinmortimer keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT paulompitrez keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT azizsheikh keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT arzuyorgancıoglu keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate
AT helenkreddel keyrecommendationsforprimarycarefromthe2022globalinitiativeforasthmaginaupdate